2022
DOI: 10.3390/pharmaceutics14061271
|View full text |Cite
|
Sign up to set email alerts
|

The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells

Abstract: In vitro transcribed mRNA for the synthesis of any given protein has shown great potential in cancer gene therapy, especially in cancer vaccines for immunotherapy. To overcome physiological barriers, such as rapid degradation by enzymatic attack and poor cellular uptake due to their large size and hydrophilic properties, many delivery carriers for mRNAs are being investigated for improving the bioavailability of mRNA. Recently, cell-penetrating peptides (CPPs) have received attention as promising tools for gen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 54 publications
0
18
0
Order By: Relevance
“…CPPs designed to target tumor tissues are used in developing a novel class of mRNA delivery tools in cancer therapy. Indeed, the presence of hydrophobic moieties, amino Frontiers in Pharmacology frontiersin.org acid composition, and structure of CPP play a major role in complex formation with mRNA and the transfection efficiency of cancer cells (Kim et al, 2022). This strategy is important to develop tumor cells-based vaccines against a variety of cancers.…”
Section: Challenges Of Using Cpps and Suggested Solutionsmentioning
confidence: 99%
See 2 more Smart Citations
“…CPPs designed to target tumor tissues are used in developing a novel class of mRNA delivery tools in cancer therapy. Indeed, the presence of hydrophobic moieties, amino Frontiers in Pharmacology frontiersin.org acid composition, and structure of CPP play a major role in complex formation with mRNA and the transfection efficiency of cancer cells (Kim et al, 2022). This strategy is important to develop tumor cells-based vaccines against a variety of cancers.…”
Section: Challenges Of Using Cpps and Suggested Solutionsmentioning
confidence: 99%
“…Compared to the covalent strategy, the non-covalent method was easier to use, produce, and preserve the function of mRNA. CPPs complexed with antigen-encoding mRNA were successfully delivered to immune cells, and facilitated mRNA escape from the endosomes to the cytosol, inducing CTL responses ( Kim et al, 2022 ). The lysine- and arginine-rich cationic peptides are able to form non-covalent complexes with nucleic acids but they require in most cases a covalent conjugation to proteins, marker molecules or drugs.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Cell-penetrating peptides (CPPs) are short cationic oligomers that cross lipid bilayer membranes without the need of transmembrane protein channels or pumps. Some CPPs transport molecular cargo into cells while others are cytotoxic . This class of biomolecules is of significant and long-standing interest for drug delivery, vaccine development, and cancer therapies. Despite this interest, there are no approved CPP-based formulations for therapeutic use in humans despite wide-scale efforts to exploit these peptides for medicinal purposes. , This exposes a fundamental gap in understanding of how CPPs selectively transverse membranes at the molecular level and how this can be exploited for therapeutic purposes.…”
Section: Introductionmentioning
confidence: 99%
“…However, the delivery of mRNA with CPPs has been less explored [ 13 , 14 ] and we are not aware of studies that compare the potential of transcript expression from pDNA vs. mRNA. Efficient in vivo transfection and subsequent protein expression is one of the limitations in further CPP use for therapeutic purposes.…”
Section: Introductionmentioning
confidence: 99%